Roberto Avellino

ORCID: 0000-0001-9554-1157
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Myeloid Leukemia Research
  • Epigenetics and DNA Methylation
  • Histone Deacetylase Inhibitors Research
  • Genomics and Chromatin Dynamics
  • Protein Degradation and Inhibitors
  • Ubiquitin and proteasome pathways
  • Blood disorders and treatments
  • Chronic Lymphocytic Leukemia Research
  • Immune Response and Inflammation
  • RNA Interference and Gene Delivery
  • Renal and related cancers
  • Gastrointestinal Tumor Research and Treatment
  • Glycosylation and Glycoproteins Research
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Cancer Genomics and Diagnostics
  • Immune cells in cancer
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Metastasis and carcinoma case studies
  • Single-cell and spatial transcriptomics
  • Hematopoietic Stem Cell Transplantation
  • Neuroblastoma Research and Treatments
  • Cell Adhesion Molecules Research
  • Advanced biosensing and bioanalysis techniques
  • Cytokine Signaling Pathways and Interactions
  • Cancer-related gene regulation

Weizmann Institute of Science
2021-2023

Erasmus MC
2011-2021

Oncode Institute
2021

Erasmus University Rotterdam
2012-2015

University of Toronto
2015

Structural Genomics Consortium
2015

We performed cytosine methylation sequencing on genetically diverse patients with acute myeloid leukemia (AML) and found leukemic DNA patterning is primarily driven by nonpromoter regulatory elements CpG shores. Enhancers displayed stronger differential than promoters, consisting predominantly of hypomethylation. AMLs dominant hypermethylation featured greater epigenetic disruption whereas those hypomethylation distal intronic regions. Mutations in IDH DNMT3A had opposing mutually exclusive...

10.1158/2159-8290.cd-16-1032 article EN Cancer Discovery 2017-04-14

C/EBPs are a family of transcription factors that regulate growth control and differentiation various tissues. We found C/EBPγ is highly upregulated in subset acute myeloid leukemia (AML) samples characterized by C/EBPα hypermethylation/silencing. Similarly, was murine hematopoietic stem/progenitor cells lacking C/EBPα, as mediates suppression. Studies demonstrated CEBPG overexpression blocked neutrophilic differentiation. Further, downregulation Cebpg Cebpa-deficient or human CEBPA-silenced...

10.1172/jci65102 article EN Journal of Clinical Investigation 2012-11-19

Acute myeloid leukemia (AML) is associated with mutations in transcriptional and epigenetic regulator genes impairing differentiation. The t(8;21)(q22;q22) translocation generates the RUNX1-ETO fusion protein, which interferes hematopoietic master RUNX1. We previously showed that maintenance of t(8;21) AML dependent on expression. Its depletion causes extensive changes transcription factor binding, as well gene expression, initiates However, how these processes are connected within a...

10.1016/j.celrep.2019.08.040 article EN cc-by Cell Reports 2019-09-01

The transcription factor C/EBPa initiates the neutrophil gene expression program in bone marrow (BM). Knockouts of Cebpa or its +37kb enhancer mice show 2 major findings: (1) neutropenia BM and blood; (2) decrease long-term hematopoietic stem cell (LT-HSC) numbers. Whether latter finding is cell-autonomous (intrinsic) to LT-HSCs an extrinsic event exerted on compartment remained open question. Flow cytometric analysis knockout model revealed that reduction LT-HSC numbers observed was...

10.1182/bloodadvances.2021005851 article EN cc-by-nc-nd Blood Advances 2021-11-23

<p>The supplementary methods contain a more detailed description of the analytic and experimental approach beyond scope main section. Supplementary Figure S1. Ability specific genomic lesions to predict epigenetic clustering. S2. ERRBS coverage. S3. Differential methylation at promoters active enhancers. S4. DMC distribution. S5. Transcription factor binding site analysis differentially methylated enhancers in IDH2, DNMT3A, IDH1/DNMT3A AMLs.</p>

10.1158/2159-8290.22533101 preprint EN cc-by 2023-04-03
Coming Soon ...